{"id":"https://openalex.org/W7161970753","doi":"https://doi.org/10.1080/13543784.2026.2674645","title":"A novel sequential ketamine and D-cycloserine/lurasidone therapy for bipolar depression with acute suicidal ideation","display_name":"A novel sequential ketamine and D-cycloserine/lurasidone therapy for bipolar depression with acute suicidal ideation","publication_year":2026,"publication_date":"2026-05-04","ids":{"openalex":"https://openalex.org/W7161970753","doi":"https://doi.org/10.1080/13543784.2026.2674645","pmid":"https://pubmed.ncbi.nlm.nih.gov/42166622"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2026.2674645","doi":"https://doi.org/10.1080/13543784.2026.2674645","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2026.2674645","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2674645","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2674645","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5136689453","display_name":"Mina Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mina Takahashi","raw_affiliation_strings":["University of Alabama at Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010294016","display_name":"Richard Charles Shelton","orcid":"https://orcid.org/0000-0002-3806-4208","observed_orcids":["https://orcid.org/0000-0002-3806-4208"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard C. Shelton","raw_affiliation_strings":["University of Alabama at Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5136689453"],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38296597,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"5","first_page":"315","last_page":"322"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.8765000104904175,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.8765000104904175,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.11959999799728394,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bipolar-depression","display_name":"bipolar depression","score":0.9869999885559082},{"id":"https://openalex.org/keywords/suicidal-ideation","display_name":"suicidal ideation","score":0.8349999785423279},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9509999752044678},{"id":"https://openalex.org/keywords/d-cycloserine","display_name":"D-cycloserine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/nmda-receptor-agonist","display_name":"NMDA receptor agonist","score":0.7409999966621399},{"id":"https://openalex.org/keywords/sequential-therapy","display_name":"sequential therapy","score":0.42899999022483826},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.47200000286102295},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.6050000190734863},{"id":"https://openalex.org/keywords/rapid-acting-antidepressants","display_name":"rapid-acting antidepressants","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2776641880","wikidata":"https://www.wikidata.org/wiki/Q944142","display_name":"Suicidal ideation","level":4,"score":0.6703000068664551},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6687999963760376},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.6625000238418579},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6110000014305115},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.499099999666214},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.43619999289512634},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3637000024318695},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.26080000400543213},{"id":"https://openalex.org/C2777342061","wikidata":"https://www.wikidata.org/wiki/Q7836891","display_name":"Treatment-resistant depression","level":4,"score":0.2596000134944916},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25600001215934753},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.25119999051094055}],"mesh":[{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13543784.2026.2674645","doi":"https://doi.org/10.1080/13543784.2026.2674645","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2026.2674645","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2674645","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:42166622","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42166622","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/13543784.2026.2674645","doi":"https://doi.org/10.1080/13543784.2026.2674645","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2026.2674645","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2674645","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","score":0.4750988781452179,"id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7161970753.pdf","grobid_xml":"https://content.openalex.org/works/W7161970753.grobid-xml"},"referenced_works_count":80,"referenced_works":["https://openalex.org/W834047622","https://openalex.org/W1946000001","https://openalex.org/W1950113474","https://openalex.org/W1969451153","https://openalex.org/W1975510992","https://openalex.org/W1980034853","https://openalex.org/W1994597913","https://openalex.org/W1996308184","https://openalex.org/W1996893328","https://openalex.org/W1997789621","https://openalex.org/W1998628114","https://openalex.org/W2009971242","https://openalex.org/W2016554932","https://openalex.org/W2018224009","https://openalex.org/W2024113682","https://openalex.org/W2026121319","https://openalex.org/W2057804290","https://openalex.org/W2064291612","https://openalex.org/W2070005343","https://openalex.org/W2077679098","https://openalex.org/W2077952072","https://openalex.org/W2079074160","https://openalex.org/W2082975629","https://openalex.org/W2100193366","https://openalex.org/W2114693958","https://openalex.org/W2119542618","https://openalex.org/W2136403062","https://openalex.org/W2139400978","https://openalex.org/W2146645762","https://openalex.org/W2155856343","https://openalex.org/W2157504436","https://openalex.org/W2160383565","https://openalex.org/W2161282771","https://openalex.org/W2166370054","https://openalex.org/W2171212397","https://openalex.org/W2216679151","https://openalex.org/W2291443053","https://openalex.org/W2306150738","https://openalex.org/W2320687740","https://openalex.org/W2579968803","https://openalex.org/W2581718547","https://openalex.org/W2790275773","https://openalex.org/W2807484787","https://openalex.org/W2903713826","https://openalex.org/W2933289315","https://openalex.org/W2945582051","https://openalex.org/W2960566636","https://openalex.org/W3011654516","https://openalex.org/W3018943821","https://openalex.org/W3019159174","https://openalex.org/W3080419142","https://openalex.org/W3119186431","https://openalex.org/W3128019732","https://openalex.org/W3129792559","https://openalex.org/W3134579316","https://openalex.org/W3156518636","https://openalex.org/W3210858906","https://openalex.org/W3212921354","https://openalex.org/W4200437000","https://openalex.org/W4213356598","https://openalex.org/W4288941091","https://openalex.org/W4295998041","https://openalex.org/W4304694995","https://openalex.org/W4307341143","https://openalex.org/W4312222233","https://openalex.org/W4376132878","https://openalex.org/W4378173498","https://openalex.org/W4384557644","https://openalex.org/W4385787511","https://openalex.org/W4387142154","https://openalex.org/W4399455554","https://openalex.org/W4403617216","https://openalex.org/W4406799600","https://openalex.org/W4408102223","https://openalex.org/W4410905192","https://openalex.org/W4410954763","https://openalex.org/W4411802932","https://openalex.org/W4413021859","https://openalex.org/W4413115468","https://openalex.org/W4414892334"],"related_works":[],"abstract_inverted_index":{"INTRODUCTION:":[0],"Bipolar":[1],"depression":[2],"with":[3,19],"acute":[4],"suicidal":[5],"ideation":[6],"and":[7,30,35,46,57,75,106,121,144,153,176,189],"behavior":[8],"(ASIB)":[9],"is":[10,52,113,123],"a":[11,20,79,99,114,133],"life-":[12],"threatening":[13],"manifestation":[14],"of":[15,78,102],"bipolar":[16,85,128],"disorder":[17],"(BD),":[18],"suicide":[21],"risk":[22],"higher":[23],"than":[24],"that":[25],"in":[26,66,83],"other":[27],"psychiatric":[28],"disorders":[29],"the":[31,55,172],"general":[32],"population.":[33,68],"Rapid":[34],"effective":[36,194],"interventions":[37],"are":[38,43,183],"critical,":[39],"as":[40],"traditional":[41],"therapies":[42],"often":[44],"slow":[45],"frequently":[47],"insufficient.":[48],"Currently,":[49],"no":[50],"drug":[51],"approved":[53],"by":[54,98],"Food":[56],"Drug":[58],"Administration":[59],"(FDA)":[60],"to":[61,108,137,149,155,185],"produce":[62],"rapid":[63,94],"anti-suicidal":[64,157],"effects":[65],"this":[67],"AREAS":[69],"COVERED:":[70],"This":[71,130],"review":[72],"examines":[73],"mechanistic":[74,145,163,191],"clinical":[76,195],"studies":[77,146,182],"two-step":[80],"therapeutic":[81,110,140],"approach":[82,136],"high-risk":[84],"depression.":[86,129],"An":[87],"initial":[88],"intravenous":[89],"(IV)":[90],"ketamine":[91],"protocol":[92],"provides":[93],"symptom":[95],"relief,":[96],"followed":[97],"maintenance":[100,187],"combination":[101],"D-":[103],"cycloserine":[104],"(DCS)":[105],"lurasidone":[107,122],"maintain":[109],"effects.":[111],"DCS":[112],"partial":[115],"N-methyl-D-":[116],"aspartate":[117],"(NMDA)":[118],"receptor":[119],"agonist,":[120],"an":[124],"FDA-approved":[125],"treatment":[126],"for":[127],"strategy":[131],"represents":[132],"mechanistically":[134],"informed":[135],"prolong":[138],"ketamine's":[139],"impact.":[141],"Relevant":[142],"trials":[143],"were":[147],"reviewed":[148],"evaluate":[150],"efficacy,":[151,171],"safety,":[152],"strategies":[154,188],"extend":[156],"benefit.":[158],"EXPERT":[159],"OPINION:":[160],"Despite":[161],"its":[162],"rationale,":[164],"uncertainties":[165],"remain":[166],"regarding":[167],"which":[168],"components":[169],"drive":[170],"optimal":[173],"dosing":[174],"strategy,":[175],"how":[177],"long":[178],"benefits":[179],"last.":[180],"Further":[181],"needed":[184],"refine":[186],"translate":[190],"insights":[192],"into":[193],"practice.":[196]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2026-05-22T00:00:00"}